| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.50▼ | 1.50▼ | 1.51▼ | 1.55▼ | 1.70▼ |
| MA10 | 1.50▼ | 1.51▼ | 1.53▼ | 1.64▼ | 1.55▼ |
| MA20 | 1.50▼ | 1.53▼ | 1.53▼ | 1.70▼ | 1.42▲ |
| MA50 | 1.52▼ | 1.55▼ | 1.62▼ | 1.51▼ | 2.09▼ |
| MA100 | 1.53▼ | 1.62▼ | 1.71▼ | 1.43▲ | 6.23▼ |
| MA200 | 1.55▼ | 1.72▼ | 1.62▼ | 1.87▼ | 18.83▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | -0.002▼ | 0.001▲ | -0.043▼ | 0.122▲ |
| RSI | 39.025▼ | 35.738▼ | 32.939▼ | 43.417▼ | 44.932▼ |
| STOCH | 36.111 | 10.260▼ | 17.433▼ | 13.780▼ | 64.453 |
| WILL %R | -71.429 | -88.889▼ | -88.889▼ | -93.750▼ | -60.326 |
| CCI | -89.017 | -126.389▼ | -115.680▼ | -129.795▼ | 37.429 |
|
Tuesday, September 09, 2025 09:28 AM
Explore Zentalis’ latest oncology advances and azenosertib updates for ovarian cancer from the 2025 Morgan Stanley Healthcare Conference.
|
|
Tuesday, September 02, 2025 02:24 PM
The 2022 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Zentalis, or following a bona fide period of non-employment, as an ...
|
|
Tuesday, August 26, 2025 09:04 AM
SAN DIEGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/09/25 | 1.54 | 1.56 | 1.485 | 1.495 | 487,683 |
| 11/09/25 | 1.46 | 1.58 | 1.46 | 1.56 | 776,550 |
| 10/09/25 | 1.60 | 1.60 | 1.46 | 1.46 | 817,483 |
| 09/09/25 | 1.63 | 1.65 | 1.59 | 1.60 | 388,362 |
| 08/09/25 | 1.75 | 1.75 | 1.63 | 1.63 | 396,576 |
| 05/09/25 | 1.77 | 1.79 | 1.71 | 1.75 | 422,390 |
| 04/09/25 | 1.71 | 1.79 | 1.60 | 1.77 | 1,050,340 |
| 03/09/25 | 1.69 | 1.82 | 1.68 | 1.71 | 417,412 |
| 02/09/25 | 1.70 | 1.815 | 1.6501 | 1.72 | 580,941 |
| 29/08/25 | 1.79 | 1.79 | 1.68 | 1.69 | 556,934 |
|
|
||||
|
|
||||
|
|